1 / 26

Virtual Medical Advisor

Virtual Medical Advisor. M. A. Conceptualized and Created by. Situation. Hi Doc, can you please forward me some good new reference on our brand @#$%&. What? I had given you those two Superb articles on this brand…. What did you do of them???. Situation.

jace
Download Presentation

Virtual Medical Advisor

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Virtual Medical Advisor M A Conceptualized and Created by

  2. Situation Hi Doc, can you please forward me some good new reference on our brand @#$%& What? I had given you those two Superb articles on this brand…. What did you do of them???

  3. Situation Doc, please don’t joke… those you had given two months back. Moreover, they were in combination treatment!. So? This is such an old molecule, there is nothing new in this that gets published.

  4. Situation Ok, I will search and will let you know in case there is something. But not today; today I am working on the new brand, next week! Doc, those were distributed last Qtr itself and don’t you have any other source other than this PubMed?

  5. Situation Thanks doc, I will work on my boss’s presentation till then. Please send it to me ASAP because then I will have to give it to vendor, designer, and printer….. Will try to revert soon, I also have to work on CME Slides and prepare a protocol for PMS!! f#@$!

  6. Situation • Don’t you think that this is a real life example? • Have you ever been a part of such communication? • Is this a regular pre Qtr meeting story? • Do you want to get out of this situation?Then…. Read on!

  7. Boston Matrix • If you are in marketing, then we don’t need to tell you the Boston Matrix

  8. Boston Matrix • But would definitely like to shift • Dogs  Cash Cows! • Just identify your Orphan Brands and tell us.

  9. Indian pharmaceutical industry • Ranked 4th by volume and 13th in value • Shares 14% of the 57 billion $ in the generic market • Could reach a size of 20 billion $ by 2015 • Will become one of the top 10 drug markets in the world But then, how many block busters did we produce?? Didn’t you have the potential??

  10. Bottlenecks for brand promotion • Pharmaceutical firms spend as much on promotion of brands (much of it directed at physicians) as on R&D • Daunting task where the market is crowded and intense • Lack of evidence based knowledge of medical representatives • Lack of focus by stakeholders, thus “Orphan brands” getting overshadowed by new entrants

  11. Solution Unlocked! • Give your Dog to our experts…. and take back the Cash Cow!

  12. What do we have to offer.. I will prepare input in pre-approved formats to significantly slash your timelines I will advise you on the ongoing developments around the world on your brand/product Virtual Medical Advisor Motivate the field by sending quick replies to the queries raised by doctors Design CME module or plan and prepare PMS documents for your product

  13. The concept… Weekly/ Monthly abstract compendium

  14. In one quarter… 1 Extended abstract 1 Extended abstract 1 Extended abstract 3 Extended Abstracts in one Qtr

  15. In one quarter… 12 Extended Abstracts in one Yr One re-written article in one Qtr

  16. In one year… • 52/ 12 compendium of abstracts published across all major journals • 12 extended abstracts ready for distribution • 4 re-written articles that can be ready to print

  17. Not Just bare information • These inputs can be incorporated in pre-approved designs. • Delivered to you in ready to print format • Can even be printed and delivered at cost beyond advisor’s cost Your VMA does it all!

  18. Objection handling • Professional objection handling • Response by e-mail • 2 – 5 Days turnaround • Provision of full text at extra cost Your VMA does it all!

  19. Continuing Medical Education • If your brand require CME • VMA suggests topic to you • After approval, prepares slides • Creates speaker notes where required • Brief’s you field officer on the topic Your VMA does it all!

  20. Post Marketing Survellience • If the product is new and important • Your VMA advices on PMS Trial • Prepares protocol • Prepares CRF • Briefs doctor via mail (if you want) on the procedure Your VMA does it all!

  21. Your VMA deliverables • 52 or 12 mails on the abstracts • 12 extended abstracts ready for distribution • 4 re-written articles that can be ready to print • Designed CDR copies ready to print • Queries handled on your product • Protocol and CRF for PMS • CME Kits

  22. Comparison

  23. Price comparison (Per Annum cost)

  24. What do you pay (Four Options) • Silver: 1,50,000 per annum* • All abstracts, Extended Abstracts, and Re-written Articles • Gold: 2,00,000 per annum * • All the silver membership benefits on pre-approved designing templates • Diamond: 3,00,000 per annum * • All the above services along with handling your brand related medical queries • Platinum: 3,50,000 per annum * • All the Diamond Membership benefits along with advice and preparation of one PMS or CME kit *Indicative cost

  25. Your VMA does it all! Please read the attached document for further details and the best idea is to write to us at admin@pharmakeez.com

  26. Disclaimer • The molecule you intend to enroll will be based on first come basis and one generic molecule will be handled for only one company because of non-compete causes. Thus, before you finalize the molecule within your organization, please write to us asking for its availability or to block it for 30 day that you will require to process the membership internally. • The cost is indicative and might vary depending on international launch and patent status for the drug. • Cost indicated is for single molecule and not for FDC (Combinations). • In case queries are to be answered by full text articles, then INR 2000 per article will be charged extra.

More Related